Verve Therapeutics Stock Market Value
| VERV Stock | USD 5.78 0.47 8.85% |
| Symbol | Verve |
Verve Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verve Therapeutics. If investors know Verve will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verve Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Revenue Per Share 0.303 | Quarterly Revenue Growth 1.202 | Return On Assets (0.22) | Return On Equity (0.41) |
The market value of Verve Therapeutics is measured differently than its book value, which is the value of Verve that is recorded on the company's balance sheet. Investors also form their own opinion of Verve Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Verve Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verve Therapeutics' market value can be influenced by many factors that don't directly affect Verve Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verve Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verve Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verve Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Verve Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Verve Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Verve Therapeutics.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Verve Therapeutics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Verve Therapeutics or generate 0.0% return on investment in Verve Therapeutics over 30 days. Verve Therapeutics is related to or competes with Adaptive Biotechnologies, Beam Therapeutics, Caribou Biosciences, Sana Biotechnology, Intellia Therapeutics, Editas Medicine, and Crispr Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to trea... More
Verve Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Verve Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Verve Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.72 | |||
| Information Ratio | 0.0112 | |||
| Maximum Drawdown | 22.1 | |||
| Value At Risk | (9.25) | |||
| Potential Upside | 8.85 |
Verve Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Verve Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Verve Therapeutics' standard deviation. In reality, there are many statistical measures that can use Verve Therapeutics historical prices to predict the future Verve Therapeutics' volatility.| Risk Adjusted Performance | 0.0375 | |||
| Jensen Alpha | 0.0033 | |||
| Total Risk Alpha | (0.54) | |||
| Sortino Ratio | 0.0111 | |||
| Treynor Ratio | 0.1177 |
Verve Therapeutics Backtested Returns
Verve Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0291, which indicates the firm had a -0.0291% return per unit of risk over the last 3 months. Verve Therapeutics exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Verve Therapeutics' Risk Adjusted Performance of 0.0375, semi deviation of 4.62, and Coefficient Of Variation of 2631.63 to confirm the risk estimate we provide. The entity has a beta of 1.43, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Verve Therapeutics will likely underperform. At this point, Verve Therapeutics has a negative expected return of -0.13%. Please make sure to validate Verve Therapeutics' sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to decide if Verve Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Verve Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Verve Therapeutics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Verve Therapeutics price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Verve Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.22 |
Verve Therapeutics lagged returns against current returns
Autocorrelation, which is Verve Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Verve Therapeutics' stock expected returns. We can calculate the autocorrelation of Verve Therapeutics returns to help us make a trade decision. For example, suppose you find that Verve Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Verve Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Verve Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Verve Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Verve Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Verve Therapeutics Lagged Returns
When evaluating Verve Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Verve Therapeutics stock have on its future price. Verve Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Verve Therapeutics autocorrelation shows the relationship between Verve Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Verve Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Verve Stock Analysis
When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.